The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats

Transplant International

Volumn 15, Issue 9-10, 2002, Pages 446-454

  Hamar, Péter ^a,b   Szabó, Attila ^b   Müller, Veronika ^b   Heemann, Uwe ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chronic allograft nephropathy; Interleukin 2; Platelet derived growth factor; T cells; Transforming growth factor

Indexed keywords

CYCLOSPORIN A; GROWTH FACTOR; INTERLEUKIN 2; PLATELET DERIVED GROWTH FACTOR; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY GRAFT; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR UPREGULATION; RISK BENEFIT ANALYSIS; RNA SYNTHESIS; SCAR FORMATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CREATININE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GROWTH SUBSTANCES; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036941129     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00198.x     Document Type: Article

References (60)

1. Abbas AK, Lichtmann AH, Pober JS (1991) Cellular and molecular immunology. Saunders, Philadelphia
2. Abboud HE (1992) Platelet-derived growth factor and mesangial cells. Kidney Int 41:581-583
3. Abbud-Filho M, Ramalho H J, Barberato JB, Corrente JE, Zerati-Filho M, Verona CB, Martucci RC, Bezas AG (1989) Inhibition of chronic kidney allograft rejection by cyclosporine. Transplant Proc 21:1660-1662
4. Agarwal SK, Dash SC, Tiwari SC, Saxena S, Mehta S, Guleria S, Dwivedi SN, Mehra NK (1995) Results of conversion from triple-drug to double-drug therapy in living related renal transplantation. Transplantation 59:27-31
5. Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL (1995) Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59:460-466
6. Border WA, Noble NA, Ketteler M (1995) TGF: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int Suppl 49:S59-S61
7. Cancedda C, Suciu Foca N, Cortesini R, Harris PE (2000) Specific T-cell deletion by transfected human monocytes expressing fas ligand and antigen. Hum Immunol 61:575-584
8. Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH (1998) Late blockade of T-cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 101:2309-2318
9. Chomczinsky P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-161
10. Dallman M J, Shiho O, Page TH, Wood K, Morris PJ (1991) Peripheral tolerance to alloantigen results from altered regulation of the interleukin-2 pathway. J Exp Med 173:79-87
11. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, Johnson RJ (1992) Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497
12. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ (1992) Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309
13. Frasca L, Amendola A, Hornick P, Brookes P, Aichinger G, Marelli Berg F, Lechler LI, Lombardi G (1998) Role of donor and recipient APC in priming and maintaining T-cells with indirect allospecificity. Transplantation 66:1238-1243
14. Frishberg Y, Meyers CM, Kelly CJ (1996) Cyclosporin A regulates T-cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int 50:45-53
15. Gaveco AS, Mitchell BL, Lucas BA, McClatchey KD, van Thiel DH (1999) CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human renal chronic allograft rejection. Kidney Int 55:1543-1552
16. Guide for the care and use of laboratory animals (1996) United States Department of Health and Human Services. NIH publication No. 85-23 (revised)
17. Halloran PF (1996) Molecular mechanisms of new immunosuppressants. Clin Transpl 10:118-123
18. Hancock W, Whitley WD, Tullius SG, Heemann UW (1993) Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56:643-650
19. Hartung J (1987) Lehr- und Handbuch der angewandten Statistik, 6th edn. Oldenburg, Munich Vienna, pp 612, 859-900
20. Heemann U, Tullius SG, Tamatami T, Miyasaka M, Milford E, Tilney NL (1994) Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts. Transpl Int 7:349-355
21. Heemann U, Azuma H, Tullius SG, Mackenzie HS, Brenner BM, Tilney NL (1994) Contribution of reduced functioning kidney mass to chronic renal allograft dysfunction in rats. Transplantation 58:1317-1322
22. Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T (1996) Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transpl Immunol 4:77-80
23. Heemann U, Azuma H, Tullius SG, Schmid C, Philipp T, Tilney NL (1996) Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. Clin Nephrol 46:34-38
24. Hollander AA, van Saase JL, Kootte AM, van Dorp WT, van Bockel HJ, Es LA, van der Woude FJ (1995) Beneficial effects of conversion from cyclosporine to azathioprine after kidney transplantation. Lancet 345:610-614
25. Hornick PI, Mason PD, Baker RJ, Hernandez Fuentes M, Frasca L, Lombardi G, Taylor K, Weng L, Rose ML, Yacoub MH, Batchelor R, Lechler RI (2000) Significant frequencies of T-cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 101:2405-2410
26. Horvath LZ, Friess H, Schilling M, Borisch B, Deflorin J, Gold LI, Korc M, Buchler MW (1996) Altered expression of transforming growth factor-S in chronic renal rejection. Kidney Int 50:489-498
27. Isoniemi H, Nurminen M, Tikkanen MJ, Willebrand, E von, Krogerus L, Ahonen J, Eklund B, Höckerstedt K, Salmela K, Häyry P (1994) Risk factors predicting chronic rejection of renal allografts. Transplantation 57:68-72
28. Jiang H, Fujitsu T, Sakuma S, Ogawa T, Tamura K, Fujii Y, Akiyama Y, Izumi S, Takahara S, Ishibashi M, Sonoda T, Shimomura K (1995) Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine. Transplant Proc 27:367-369
29. Kelly KE, Hertz MI, Mueller DL (1998) T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation 66:764-771
30. Kirk AD, Jacobson LM, Heisey DM, Radke NF, Pirsch JD, Sollinger HW (1999) Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation 68:1578-1582
31. Koskinen PK, Lemström KB, Häyry PJ (1995) How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol 146:972-980
32. Krams SM, Falco DA, Villaneuva JC, Rabkin J, Tomlanovich S J, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP, Ascher NL, Martinez OM (1992) Cytokine and T-cell gene expression at the site of allograft rejection. Transplantation 53:151-156
33. Legar JF, lssekutz T, Lee TD, Hirsch G (2000) CD8+ T-lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol 157:859-865
34. Lemström KB, Räisänen-Sokolowski AK, Häyry PJ, Koskinen PK (1996) Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 16:553-564
35. Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M (1991) Differential regulation of transforming growth factor- and interleukin-2 genes in human T-cells: Demonstration of usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 174:1259-1262
36. Lowry RP, Takeuchi T, Cremisi H, Konieczny B, Someren A (1993) Chronic rejection of organ allografts may arise from injuries sustained in recurring loci of acute rejection that resolve spontaneously. Transplant Proc 25:2103-2105
37. Muchaneta-Kubara EC, Sayed-Ahmed N, El Nahas AM (1995) Subtotal nephrectomy: a mosaic of growth factors. Nephrol Dial Transplant 10:320-327
38. Nadeau KC, Azuma H, Tilney NL (1995) Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 92:8729-8733
39. Nowaczky M, Gorski A, Korczak-Kowalska G, Wierzbicki P, Wyzgal J, Durlik M, Orlowska A (1998) Lymphocyte interactions with extracellular matrix proteins and endothelium in renal allograft recipients. Arch Immunol Ther Exp 46:35-38
40. Nowaczyk M, Gorski A, Durlik M, Wyzgal J, Perkowska-Francka (1999) A role of adhesion molecules in chronic allograft nephropathy. Arch Immunol Ther Exp 47:373-375
41. Olive C, Cheung C, Falk MC (1999) Apoptosis and expression of cytotoxic T-lymphocyte effector molecules in renal allografts. Transpl Immunol 7: 27-36
42. O'Neil EA, Tocci MJ (1993) Transcriptional activation of the IL-2 gene. Transplant Sci 3:77-82
43. Orosz CG (1996) Local cellular immunology of experimental transplant vascular sclerosis. Clin Transpl 10:100-103
44. Ostendorf T, Burg M, Floege J (1996) Cytokines and glomerular injury. Kidney Blood Press Res 19:281-289
45. Pabico RC, Yarger J, Byer B, Kremer M, McKenna BA, Cerilli GJ (1994) Effects of cyclosporin A on chronic renal transplant rejection. Transplant Proc 26:2577-2579
46. Paul LC (1995) Chronic renal transplant loss. Kidney Int 47:1491-1496
47. Paul LC, Saito K, Davidoff A, Benediktsson H (1996) Growth factor transcripts in rat renal transplants. Am J Kidney Dis 28:441-450
48. Rennke HG, Klein PS (1989) Pathogenesis and significance of non-primary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443-456
49. Rosenblum ND, Harmon WE, Levey RH (1988) Treatment of chronic renal allograft rejection with cyclosporine and prednisolone. Transplantation 45:232-233
50. Schleimer K, Szabó A, Müller V, Hamar P, Heemann UW (1997) Influence of the ace-inhibitor enalapril on the development of chronic rejection after orthotopic renal transplantation in the rat. Langenbecks Arch Surg 1:1-5
51. Schmid C, Heemann U, Tilney NL (1996) Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. Transplantation 61:1695-1699
52. Schwarze ML, Menard MT, Fuchimoto Y, Huang CA, Houser S, Mawulawde K, Allison KS, Sachs DH, Madsen JC (2000) Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine. Ann Thorac Surg 70:131-138
53. Shihab FS, Yamamoto T, Nast C, Cohen AH, Noble NA, Gold LI, Border WA (1995) Transforming growth factor- and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294
54. Shihab FS, Tanner AM, Shao Y, Weffer MI (1996) Expression of TGF-1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 50:1904-1913
55. Slachta CA, Jeevanandam V, Goldman B, Lin WL, Platsoucas CD (2000) Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T-cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). J Immunol 165:3469-3483
56. Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240:1169-1176
57. Suciu-Foca N, Harris PE, Cortesini R (1998) Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev 164:241-246
58. Vischjager M, van Gulik TM, Kleine RHJ de, van Marie J, Pfaffendorf M, Klopper PJ, Jacobs MJ (1996) Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression. Transplantation 61:1138-1142
59. Wolf G, Thaiss F, Stahl RA (1995) Cyclosporine stimulates expression of transforming growth factor in renal cells. Possible mechanism of cyclospofine's antiproliferative effects. Transplantation 60:237-241
60. Yoshimura N, Oka T, Amagai T, Horii Y, Imanishi J (1991) Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A. Clin Exp Immunol 85:326-330